Le groupe Clarenta accueille Leads To Development pour renforcer ses compétences en matière de développement de médicaments au stade précoce
<p>LONDRES, 1er octobre 2026 /PRNewswire/ -- Clarenta a annoncé aujourd'hui que Leads To Development (L2D) avait rejoint son groupe à la suite d'une prise de participation majoritaire qui consolide la capacité de Clarenta à accompagner les promoteurs biotechnologiques et pharmaceutiques...</p>
Read original article ↗
Related Articles
SK hynix reiterates no decision on Solidigm's US IPO
SK hynix said Thursday it is reviewing various funding options for its U.S. subsidiary Solidigm but that no decision has
LS Electric wins $133 mil. transformer deal in US
LS Electric Co., a Korean electrical equipment maker, said Thursday it has secured a 180 billion-won ($133 million) cont
Samsung chief joins chip industry leaders at Korean art gala in London
Samsung Electronics Executive Chairman Lee Jae-yong joined global business leaders at a London gala celebrating a Korean
Europe Today: Rutte tells Russia to stop nuclear threats at Euronews defence summit
NATO chief Mark Rutte tells Russia to stop its nuclear threats, speaking at the Euronews Defence Summit as Moscow threat